Outcomes of follow-up oral food challenges in young children on oral immunotherapy
Journal of Food Allergy · 01.07.2026 · 8 (1) · 51-54
DOI: 10.2500/jfa.2026.8.260005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Food Allergy, erschienen am 01.07.2026. Verfasst von Srushti Raja und 2 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Oral immunotherapy (OIT) has been demonstrated to be safe in young children, including preschool age children. There are limited data with regard to long-term outcomes after achieving maintenance OIT (mOIT) for very young children.
Objective
Our study aimed to provide data on outcomes of oral food challenges (OFC) conducted in young children after time on mOIT and subsequent integration of specific food allergens into the daily diet.
Methods
The institutional review board approved chart review was conducted of 96 patients who began OIT at ages ≤5 years (average 23 months) who underwent OFCs after reaching mOIT. Demographics, length of mOIT, testing, cumulative OFC protein dose, recommendations after OFC, and any adverse reactions after OFC while freely consuming the index allergen were collected.
Results
Of 96 patients, 30 received multifood OIT. There were 123 OFCs in total: peanut (67), cashew (27), sesame (12), walnut (11), baked egg (2), milk (1), baked milk (1), wheat (2). OFCs were offered after a mean of 12.7 months on mOIT (range 4 to 47 months). The patients continued daily dosing until OFC. Children consumed variable protein amounts of index food during the OFC (2 g to 8.8 g). All OFCs were completed without reaction requiring treatment, and the patients were advised to consume the index food a minimum of twice weekly in large servings. At OFC follow-up (average 16 months after OFC), 89 of the 96 patients (93%) were documented to be free-eating. Several patients reported oral itching, but no patients discontinued index food consumption (although one patient was lost to follow-up).
Conclusion
OIT in very young children offers considerable protection beyond “bite-proof” dosing, which allows many patients to transition to free-eating, which demonstrated favorable long-term efficacy in this age group. More studies are needed to identify optimal dosing and laboratory markers that can be used to identify when OFC is appropriate while on mOIT.
Zitieren
APA
Raja, S., McNamara, K., & Bjelac, J. (2026). Outcomes of follow-up oral food challenges in young children on oral immunotherapy. Journal of Food Allergy, 8(1), 51-54. https://doi.org/10.2500/jfa.2026.8.260005
Vancouver
Raja S, McNamara K, Bjelac J. Outcomes of follow-up oral food challenges in young children on oral immunotherapy. Journal of Food Allergy. 2026;8(1):51-54. doi:10.2500/jfa.2026.8.260005
BibTeX
@article{Raja2026,
author = {Raja, Srushti and McNamara, Kara and Bjelac, Jaclyn},
title = {Outcomes of follow-up oral food challenges in young children on oral immunotherapy},
journal = {Journal of Food Allergy},
year = {2026},
volume = {8},
number = {1},
pages = {51--54},
doi = {10.2500/jfa.2026.8.260005}
}
EUVIMED